RJ Scheper

633 total citations
16 papers, 557 citations indexed

About

RJ Scheper is a scholar working on Oncology, Molecular Biology and Rheumatology. According to data from OpenAlex, RJ Scheper has authored 16 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Rheumatology. Recurrent topics in RJ Scheper's work include Drug Transport and Resistance Mechanisms (7 papers), Cancer therapeutics and mechanisms (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). RJ Scheper is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Cancer therapeutics and mechanisms (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). RJ Scheper collaborates with scholars based in Netherlands, United States and Germany. RJ Scheper's co-authors include Steven T. Pals, E Horst, Carl G. Figdor, CJ Meijer, Elisabeth G.E. de Vries, HJ Broxterman, ML Slovak, G L Scheffer, Coby Meijer and Hetty Timmer‐Bosscha and has published in prestigious journals such as Blood, British Journal of Cancer and The Journal of Pathology.

In The Last Decade

RJ Scheper

16 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RJ Scheper Netherlands 10 322 281 74 64 58 16 557
Xiu Feng Hu Australia 14 310 1.0× 406 1.4× 110 1.5× 29 0.5× 67 1.2× 24 621
Mark DeMario United States 14 402 1.2× 437 1.6× 67 0.9× 30 0.5× 82 1.4× 25 809
J. H. Doroshow United States 14 247 0.8× 187 0.7× 56 0.8× 15 0.2× 45 0.8× 30 543
Sharon Wu United States 13 247 0.8× 274 1.0× 42 0.6× 36 0.6× 53 0.9× 68 604
GJ Schuurhuis Netherlands 14 375 1.2× 293 1.0× 39 0.5× 96 1.5× 240 4.1× 18 701
Mark G. Federici United States 12 228 0.7× 201 0.7× 104 1.4× 14 0.2× 23 0.4× 14 635
M.J. Millward Australia 13 580 1.8× 403 1.4× 55 0.7× 15 0.2× 24 0.4× 31 842
D. M. Moccio United States 16 260 0.8× 393 1.4× 108 1.5× 82 1.3× 133 2.3× 21 920
M Volm Germany 13 459 1.4× 293 1.0× 44 0.6× 18 0.3× 27 0.5× 42 749
Yoko Okitsu Japan 15 198 0.6× 320 1.1× 61 0.8× 34 0.5× 186 3.2× 49 647

Countries citing papers authored by RJ Scheper

Since Specialization
Citations

This map shows the geographic impact of RJ Scheper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RJ Scheper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RJ Scheper more than expected).

Fields of papers citing papers by RJ Scheper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RJ Scheper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RJ Scheper. The network helps show where RJ Scheper may publish in the future.

Co-authorship network of co-authors of RJ Scheper

This figure shows the co-authorship network connecting the top 25 collaborators of RJ Scheper. A scholar is included among the top collaborators of RJ Scheper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RJ Scheper. RJ Scheper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gerards, A., et al.. (2013). Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients. Scandinavian Journal of Rheumatology. 43(1). 9–16. 12 indexed citations
2.
Scheper, RJ, et al.. (2006). Expression of drug pathway proteins is independent of tumour type. The Journal of Pathology. 209(2). 213–219. 33 indexed citations
3.
Gerards, A., Ruud Oerlemans, RJ Scheper, et al.. (2005). Inhibition of tumour necrosis factor alpha production by activated T cells of rheumatoid arthritis patients by novel anti-folate drugs: an ex vivo pilot study. Arthritis Research. 7(Suppl 1). P84–P84. 2 indexed citations
4.
Moed, H. D., Jacoba Flier, D. M. Boorsma, et al.. (2004). FS02.2
CD4+ CCR10+ effector T cells reside at former allergic contact dermatitis sites. Contact Dermatitis. 50(3). 129–130. 2 indexed citations
5.
Kamps, WA, et al.. (2003). Functional activity of breast cancer resistance protein (BCRP) in acute lymphoblastic leukemia. Data Archiving and Networked Services (DANS). 17(3). 662–662. 3 indexed citations
6.
Jansen, Gerrit, et al.. (2002). Molecular mechanisms of resistance to disease modifying antirheumatic drugs (DMARDs). Arthritis Research. 4(Suppl 1). 51–51. 2 indexed citations
7.
Maliepaard, Marc, et al.. (2000). CAMPTOTHECINS: UNFOLDING THEIR ANTICANER POTENTIAL. 1 indexed citations
8.
Beck, James F., Peter Bader, J. Dietl, et al.. (1998). Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC η with MDR1, MRP and LRP gene expression. British Journal of Cancer. 77(1). 87–91. 41 indexed citations
9.
10.
Boer, Monique L. den, C. Michel Zwaan, R. Pieters, et al.. (1997). Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia. Leukemia. 11(7). 1078–1085. 41 indexed citations
11.
12.
Slovak, ML, Susan P.C. Cole, Elisabeth G.E. de Vries, et al.. (1995). The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification.. PubMed. 55(19). 4214–9. 82 indexed citations
13.
Schuurhuis, GJ, HJ Broxterman, H. M. Pinedo, et al.. (1991). Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. British Journal of Cancer. 64(5). 857–861. 93 indexed citations
14.
Vries, Elisabeth G.E. de, et al.. (1990). Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up. Lung Cancer. 6(1-2). 47–47. 66 indexed citations
15.
Pals, Steven T., et al.. (1989). Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood. 73(4). 885–888. 8 indexed citations
16.
Pals, Steven T., et al.. (1989). Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood. 73(4). 885–888. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiu Feng Hu Breakdown of academic impact, for papers by Mark DeMario Breakdown of academic impact, for papers by J. H. Doroshow Breakdown of academic impact, for papers by Sharon Wu Breakdown of academic impact, for papers by GJ Schuurhuis Breakdown of academic impact, for papers by Mark G. Federici Breakdown of academic impact, for papers by M.J. Millward Breakdown of academic impact, for papers by D. M. Moccio Breakdown of academic impact, for papers by M Volm Breakdown of academic impact, for papers by Yoko Okitsu
Rankless by CCL
2026